Audimax of the LIMES Institute
Meet Jonathan Koltula, CEO of LagunaBio, the California-based startup working on immunotherapy against cancer, to discuss how the startup world is working, how to transition, when you need a patent, and how the research landscape looks like in the US nowadays.
Meet Jonathan Koltula, CEO of LagunaBio, the California-based startup working on immunotherapy against cancer, to discuss how the startup world is working, how to transition, when you need a patent, and how the research landscape looks like in the US nowadays.
Register now for the round table discussion
About the speaker
Jonathan Kotula, PhD is driven to pursue biotechnology solutions for human health challenges. He is an expert in synthetic biology and host-microbial interactions, with over 20 years of research and development experience. He is the CEO and founder of Laguna Bio, a company that pursues research exploring how to activate and expand the endogenous immune system to with living biotherapeutics. Previously he was the Entrepreneur in Residence and Director of New Ventures at Spero New Ventures and has led interdisciplinary teams of researchers to develop living microbial therapeutics, and initiated clinical research programs at Synlogic, Caribou Biosciences, and Felix Biotechnology. He advises several early-stage biotech companies, and is an inventor on several bacterial genome editing patents. He holds a BS from Pennsylvania State University in Biochemistry and Molecular Biology, a PhD from Duke University in Molecular Genetics and Microbiology and has conducted postdoctoral research at Harvard Medical School and the Wyss Institute for Biologically Inspired Engineering.